Clinical Trial Update: Xience Versus Synergy in Left Main PCI [NA]

View source ↗

Summary

Trial update comparing Xience and Synergy drug-eluting stents for left main coronary artery disease; no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Synergy
• Xience (everolimus-eluting stent with permanent polymer)

Snippet

Sponsor: NHS National Waiting Times Centre Board | Conditions: Coronary Artery Disease | NA | Status: UNKNOWN